These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 38438169)
21. Minimally Invasive Pelvic Exenteration for Gynecologic Malignancies: A Multi-Institutional Case Series and Review of the Literature. Bizzarri N; Chiantera V; Ercoli A; Fagotti A; Tortorella L; Conte C; Cappuccio S; Di Donna MC; Gallotta V; Scambia G; Vizzielli G J Minim Invasive Gynecol; 2019; 26(7):1316-1326. PubMed ID: 30611973 [TBL] [Abstract][Full Text] [Related]
22. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Berek JS; Howe C; Lagasse LD; Hacker NF Gynecol Oncol; 2005 Oct; 99(1):153-9. PubMed ID: 16054678 [TBL] [Abstract][Full Text] [Related]
23. Pelvic exenteration and reconstruction. Salom EM; Penalver MA Cancer J; 2003; 9(5):415-24. PubMed ID: 14690317 [TBL] [Abstract][Full Text] [Related]
24. Primary vaginal reconstruction at the time of pelvic exenteration for gynecologic cancer: morbidity revisited. Jurado M; Bazán A; Alcázar JL; Garcia-Tutor E Ann Surg Oncol; 2009 Jan; 16(1):121-7. PubMed ID: 18941843 [TBL] [Abstract][Full Text] [Related]
25. The double-barrel wet colostomy: An alternative for urinary diversion after pelvic exenteration. Wright JP; Guerrero WM; Lucking JR; Bustamante-Lopez L; Monson JRT Surgeon; 2023 Dec; 21(6):375-380. PubMed ID: 37087331 [TBL] [Abstract][Full Text] [Related]
26. Pelvic Exenteration in Advanced Gynecologic Malignancies - Who Will Benefit? Egger EK; Liesenfeld H; Stope MB; Recker F; Döser A; Könsgen D; Marinova M; Hilbert T; Exner D; Ellinger J; Mustea A Anticancer Res; 2021 Jun; 41(6):3037-3043. PubMed ID: 34083295 [TBL] [Abstract][Full Text] [Related]
27. Comparison of postoperative complications and quality of life between patients undergoing continent versus non-continent urinary diversion after pelvic exenteration for gynecologic malignancies. Angeles MA; Mallet E; Rouanet P; Cabarrou B; Méeus P; Lambaudie E; Foucher F; Narducci F; Loaec C; Gouy S; Guyon F; Marchal F; Gladieff L; Martínez-Gómez C; Migliorelli F; Martinez A; Ferron G Int J Gynecol Cancer; 2020 Feb; 30(2):233-240. PubMed ID: 31796531 [TBL] [Abstract][Full Text] [Related]
28. Robotic Pelvic Exenteration for Gynecologic Malignancies, Anatomic Landmarks, and Surgical Steps: A Systematic Review. Cianci S; Arcieri M; Vizzielli G; Martinelli C; Granese R; La Verde M; Fagotti A; Fanfani F; Scambia G; Ercoli A Front Surg; 2021; 8():790152. PubMed ID: 34917648 [TBL] [Abstract][Full Text] [Related]
29. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall. Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694 [TBL] [Abstract][Full Text] [Related]
30. The role of pelvic exenteration and reconstruction for treatment of advanced or recurrent gynecologic malignancies: Analysis of risk factors predicting recurrence and survival. Park JY; Choi HJ; Jeong SY; Chung J; Park JK; Park SY J Surg Oncol; 2007 Dec; 96(7):560-8. PubMed ID: 17708548 [TBL] [Abstract][Full Text] [Related]
31. Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003). Goldberg GL; Sukumvanich P; Einstein MH; Smith HO; Anderson PS; Fields AL Gynecol Oncol; 2006 May; 101(2):261-8. PubMed ID: 16426668 [TBL] [Abstract][Full Text] [Related]
32. [Vaginal reconstruction after pelvic exenteration: when and which techniques?]. Ferron G; Martel P; Querleu D Bull Cancer; 2003 May; 90(5):435-40. PubMed ID: 12868455 [TBL] [Abstract][Full Text] [Related]
33. Pelvic exenteration: a review of current issues/controversies. Shine RJ; Glyn T; Frizelle F ANZ J Surg; 2022 Nov; 92(11):2822-2828. PubMed ID: 35490337 [TBL] [Abstract][Full Text] [Related]
34. Role of MR Imaging and FDG PET/CT in Selection and Follow-up of Patients Treated with Pelvic Exenteration for Gynecologic Malignancies. Lakhman Y; Nougaret S; Miccò M; Scelzo C; Vargas HA; Sosa RE; Sutton EJ; Chi DS; Hricak H; Sala E Radiographics; 2015; 35(4):1295-313. PubMed ID: 26172364 [TBL] [Abstract][Full Text] [Related]
35. The role of imaging in pelvic exenteration for gynecological cancers. Causa Andrieu PI; Woo S; Rios-Doria E; Sonoda Y; Ghafoor S Br J Radiol; 2021 Sep; 94(1125):20201460. PubMed ID: 33960814 [TBL] [Abstract][Full Text] [Related]
36. [Clinical study of using basement membrane biological products in pelvic floor reconstruction during pelvic exenteration]. Chen GL; Wang YL; Zhang X; Tao Y; Sun YH; Chen JN; Wang SQ; Su N; Wang ZG; Zhang J Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):268-276. PubMed ID: 36925127 [No Abstract] [Full Text] [Related]
37. Surgical results of pelvic exenteration in the treatment of gynecologic cancer. Petruzziello A; Kondo W; Hatschback SB; Guerreiro JA; Filho FP; Vendrame C; Luz M; Ribeiro R World J Surg Oncol; 2014 Sep; 12():279. PubMed ID: 25200866 [TBL] [Abstract][Full Text] [Related]
38. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies. Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370 [TBL] [Abstract][Full Text] [Related]
39. A novel technique for surgical reconstruction of the perineal floor following anteroposterior exenteration of the pelvis--case report and review of the literature. Kyriazi MA; Stafyla VK; Kondi-Pafiti A; Arkadopoulos N; Dafnios N; Hasiakos D; Fotiou S; Mastorakos D; Smyrniotis V Eur J Gynaecol Oncol; 2010; 31(2):201-5. PubMed ID: 20527241 [TBL] [Abstract][Full Text] [Related]